+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Avastin"

Brain Tumor Drugs Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Brain Tumor Drugs Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Colorectal Cancer Therapeutics: Global Markets - Product Thumbnail Image

Colorectal Cancer Therapeutics: Global Markets

  • Report
  • March 2019
  • 124 Pages
  • Global
From
Brain Tumor Therapeutics: Global Markets to 2023 - Product Thumbnail Image

Brain Tumor Therapeutics: Global Markets to 2023

  • Report
  • December 2018
  • 161 Pages
  • Global
From
From
Loading Indicator

Avastin is a drug used in the treatment of certain types of cancer. It is a monoclonal antibody that works by blocking the growth of new blood vessels that tumors need to grow. Avastin is used to treat a variety of cancers, including colorectal, lung, kidney, and ovarian cancer. It is also used to treat metastatic breast cancer. Avastin is administered intravenously and is often used in combination with other cancer treatments, such as chemotherapy and radiation therapy. Avastin is a key drug in the oncology market, as it is used to treat a variety of cancers. It is one of the most widely used cancer drugs in the world, and is often used in combination with other treatments. Avastin is a valuable tool in the fight against cancer, as it can help slow the growth of tumors and prolong the lives of patients. Some of the companies in the Avastin market include Roche, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more